banner
Inquiry

Cat. No.: X24-09-YM789

Ko-143, Purity ≥98%

Synonym: 461054-93-3; Ko 143; Ko143; Tert-butyl 3-[(2S,5S,8S)-14-methoxy-2-(2-methylpropyl)-4,7-dioxo-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraen-5-yl]propanoate

  • MDL: MFCD11042273
  • CAS Number: 461054-93-3
  • Compound CID: 10322450
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Ko-143, soluble in DMSO and ethanol and insoluble in water, is a potent and selective inhibitor of breast cancer resistance protein multidrug transporter (BCRP). The molecular weight of the compound is 469.59, and its molecular formula is C26H35N3O5.
Molecular Weight
469.59
Molecular Formula
C26H35N3O5
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Solubility
In vitro: DMSO: 89 mg/mL (189.53 mM); Water: insoluble; Ethanol: 89 mg/mL (189.53 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Ko-143 can be used for its potential to overcome drug resistance in cancer therapy by enhancing the efficacy of chemotherapeutic agents that are substrates for this transporter.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0